The advent of novel high-throughput sequencing methods has facilitated identification of
non-coding RNAs with fundamental roles in cellular biological and pathological conditions …

Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …

Bladder cancer (BC) is the most common malignant tumor in the urinary system, and its early
diagnosis is conducive to improving clinical prognosis and prolonging overall survival time …

Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …

Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature
of several human cancers. However, the genome‑wide expression and functional …

Purpose: Loss of epigenetic gene regulation through altered long noncoding RNA (lncRNA)
expression seems important in human cancer. LncRNAs have diagnostic and therapeutic …

To understand lncRNAs expression profiling and their potential functions in bladder cancer,
we investigated the lncRNA and coding RNA expression on human bladder cancer and …

Human bladder cancer (BCa) is one of the most commonly diagnosed malignancies
worldwide. It has high recurrence rates and low-grade malignancy, thus representing an …

The mammalian genome encodes thousands of long noncoding RNAs (lncRNAs) and it is
increasingly clear that lncRNAs are key regulators of cellular function and development …

Long non-coding RNAs (lncRNAs) are regulators of cellular machinery that are commonly
dysregulated in genitourinary malignancies. Accordingly, the investigation of lncRNAs is …